Source: Virtual Congress 2021 – Different treatment modalities and impact of comorbidities on sleep disordered breathing



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Peker (Istanbul, Turkey), M. Saygin (Isparta, Turkey), E. Thunström (Gothenburg, Sweden), P. J Strollo Jr (Pittsburgh, United States of America). Natural course of untreated obstructive sleep apnoea in patients with coronary artery disease in the RICCADSA trial. 4388

Member's Comments

No comment yet.

Related content which might interest you: High prevalence of obstructive sleep apnoea in revascularized patients with coronary artery disease – RICCADSA trial Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea Year: 2008 Cardiovascular outcomes in patients with coronary artery disease and nonsleepy versus sleepy obstructive sleep apnoea phenotypes in the RICCADSA trial Source: Virtual Congress 2021 – The different faces of sleep disturbances in respiratory diseases and beyond Year: 2021 Outcomes in coronary artery disease patients with sleepy obstructive sleep apnoea on CPAP Source: Eur Respir J, 50 (6) 1700749; 10.1183/13993003.00749-2017 Year: 2017 Clinical and polysomnographic determinants of REM predominant obstructive sleep apnoea and response to treatment in a revascularized coronary artery disease cohort Source: Virtual Congress 2020 – Diagnostic characteristics and consequences of sleep and breathing disorders Year: 2020 Increased incidence of coronary artery disease in sleep apnoea: a long-term follow-up Source: Eur Respir J 2006; 28: 596-602 Year: 2006 Increased incidence of coronary artery disease in obstructive sleep apnoea: a seven-year follow-up Source: Eur Respir J 2001; 18: Suppl. 33, 518s Year: 2001 Influence of obstructive sleep apnea in coronary artery disease: an 8-years-follow-up Source: Eur Respir J 2003; 22: Suppl. 45, 22s Year: 2003 Adherence to CPAP treatment in patients with coronary artery disease and obstructive sleep apnoea without sleepiness: a preliminary report from the riccadsa trial Source: Annual Congress 2009 - Cardiovascular complications in obstructive sleep apnoea Year: 2009 Polysomnographic characteristics and cardiac function in coronary artery disease patients with nonsleepy obstructive sleep apnoea Source: International Congress 2018 – Epidemiology, phenotypes and cardiometabolic comorbidities of obstructive sleep apnoea Year: 2018 Late Breaking Abstract: Baseline characteristics of the revascularized patients with coronary artery disease and obstructive sleep apnoea in the RICCADSA trial Source: Annual Congress 2010 - Sleep apnoea: insights from basic and clinical research Year: 2010 Late-breaking abstract: Cardiac function in a revascularized coronary artery disease cohort with obstructive sleep apnoea with and without daytime sleepiness in the RICCADSA trial Source: Annual Congress 2011 - Obstructive sleep apnoea in children and adults Year: 2011 CPAP treatment increases anxiety in coronary artery disease patients with nonsleepy obstructive sleep apnoea: The RICCADSA randomized controlled trial Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence Year: 2020 Heart rate turbulence: In patients with obstructive sleep apnea without coronary artery diseases Source: Annual Congress 2011 - Obstructive sleep apnoea: the heart and the brain Year: 2011 CPAP does not reduce inflammatory biomarkers in coronary artery disease patients with nonsleepy obstructive sleep apnoea: a randomized controlled trial Source: International Congress 2017 – CPAP therapy Year: 2017 Depression and response to CPAP treatment in coronary artery disease patients with sleepy vs nonsleepy obstructive slee apnoea Source: International Congress 2018 – Epidemiology, phenotypes and cardiometabolic comorbidities of obstructive sleep apnoea Year: 2018 Obstructive sleep apnoea and coronary artery disease Source: International Congress 2016 – PG18 Sleep apnoea and comorbidities Year: 2016 Atherosclerosis of the carotid arteries in patients with COPD and obstructive sleep apnea (OSA). Source: International Congress 2017 – Central sleep apnoea: consequences and comorbidities of obstructive sleep apnoea Year: 2017 Long-term effects of cardiac rehabilitation on sleep apnea severity in patients with coronary artery disease Source: International Congress 2017 – CPAP therapy Year: 2017 Association between obstructive sleep apnea syndrome and coronary atherosclerostic disease Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders Year: 2007 Prevalence of cardiovascular risk factors and coronary artery disease in patients with obstructive sleep apnea syndrome (OSAS) requiring CPAP treatment Source: Eur Respir J 2006; 28: Suppl. 50, 814s Year: 2006